{"paper_id":"0ed15afa-d787-4ac8-8fd0-1fa67c7f88e1","body_text":"Abstract\nPelvic endometriosis remains a difficult gynaecological problem to manage and yet the progression of the disease can be very detrimental to the health of the patients. Surgical treatment often involves removal of the reproductive as well as the hormonal functions of the patient. With the discovery of GnRH analogues ability to induce reversible suppression of the hypothalamic-pituitary-ovarian axis, it becomes possible to produce a hypoestrogenic state which allows regression of the disease. This paper reports on a Phase III clinical trial on the use of buserelin (Hoechst China Ltd) in the management of patients with severe pelvic endometriosis.\nPreview\nUnable to display preview. Download preview PDF.\nSimilar content being viewed by others\nAuthor information\nAuthors and Affiliations\nEditor information\nRights and permissions\nCopyright information\n© 1990 Kluwer Academic Publishers\nAbout this chapter\nCite this chapter\nLi, D.F.H., Ho, P.C. (1990). Management of Pelvic Endometriosis with a GnRH Analogue. In: Vickery, B.H., Lunenfeld, B. (eds) GnRH Analogues in Reproduction and Gynecology. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-0721-8_6\nDownload citation\nDOI: https://doi.org/10.1007/978-94-009-0721-8_6\nPublisher Name: Springer, Dordrecht\nPrint ISBN: 978-94-010-6809-3\nOnline ISBN: 978-94-009-0721-8\neBook Packages: Springer Book Archive\nKeywords\nThese keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.","source_license":"CC0","license_restricted":false}